MN

Mohd Nasir

Active Director Managing Director DIN 07100940
DIN 07100940 First appointment Mar 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2015
Shareholding value •••• Premium profile

About Mohd Nasir

Data last updated:

Mohd Nasir is a Managing Director at Mnc Biotech Private Limited (since 2015). The company operates in Pharma. Mnc Biotech Private Limited reported revenue of ₹1.93 Cr (FY 2025).

DIN 07100940
Primary Designation Managing Director
Industry Pharma
First Appointment 20 Mar 2015
Oldest Company Age 11 yrs
Largest company Mnc Biotech Private Limited · ₹1.93 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mnc Biotech Private Limited U24233UP2015PTC069668
Managing Director20 Mar 20152015₹1.93 Cr (FY 2025)Active

Board colleagues of Mohd Nasir

NameDINCompanyDesignation
Mukhtar Nizami07100935Mnc Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mnc Biotech Private Limited
Premium access

Shareholding and investment profile for Mohd Nasir

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohd Nasir

Mohd Nasir currently holds 1 directorship: Mnc Biotech Private Limited (Managing Director, since 20 Mar 2015, revenue ₹1.93 Cr (FY 2025)).

Mohd Nasir was first appointed on 20 Mar 2015 as Managing Director at Mnc Biotech Private Limited.

The current boards of Mohd Nasir's companies include Mukhtar Nizami (Mnc Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available